Inhibition of GSK3 differentially modulates NF-κB, CREB, AP-1 and β-catenin signaling in hepatocytes, but fails to promote TNF-α-induced apoptosis

Experimental Cell Research

Volumn 314, Issue 6, 2008, Pages 1351-1366

  Götschel, Frank ^a   Kern, Claudia ^a   Lang, Simona ^a   Sparna, Titus ^a   Markmann, Cordula ^a   Schwager, Joseph ^b   McNelly, Sabine ^c   von Weizsäcker, Fritz ^c   Laufer, Stefan ^d   Hecht, Andreas ^a   Merfort, Irmgard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AP 1; Apoptosis; CREB; Glycogen synthase kinase 3; Hepatocyte; Liver; NF B; TNF ; Wnt; catenin

Indexed keywords

BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

EID: 40049099291     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.12.015     Document Type: Article

References (78)

1. B.W. Doble J.R. Woodgett GSK-3: tricks of the trade for a multi-tasking kinase J. Cell Sci. 116 2003 1175 1186
2. R.S. Jope G.V. Johnson The glamour and gloom of glycogen synthase kinase-3 Trends Biochem. Sci. 29 2004 95 102
3. N. Embi D.B. Rylatt P. Cohen Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase Eur. J. Biochem. 107 1980 519 527
4. J.R. Woodgett Molecular cloning and expression of glycogen synthase kinase-3/factor A Embo J. 9 1990 2431 2438
5. B.P. Zhou J. Deng W. Xia J. Xu Y.M. Li M. Gunduz M.C. Hung Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition Nat. Cell Biol. 6 2004 931 940
6. D.A. Cross D.R. Alessi P. Cohen M. Andjelkovich B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
7. X. Liu J.S. Rubin A.R. Kimmel Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins Curr. Biol. 15 2005 1989 1997
8. K.P. Hoeflich J. Luo E.A. Rubie M.S. Tsao O. Jin J.R. Woodgett Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation Nature 406 2000 86 90
9. A.A. Beg W.C. Sha R.T. Bronson S. Ghosh D. Baltimore Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B Nature 376 1995 167 170
10. M. Tanaka M.E. Fuentes K. Yamaguchi M.H. Durnin S.A. Dalrymple K.L. Hardy D.V. Goeddel Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice Immunity 10 1999 421 429
11. F. Geisler H. Algul S. Paxian R.M. Schmid Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132 2007 2489 2503
12. R.F. Schwabe D.A. Brenner Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes Am. J. Physiol., Gastrointest. Liver Physiol. 283 2002 G204 G211
13. Y. Takada X. Fang M.S. Jamaluddin D.D. Boyd B.B. Aggarwal Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor J. Biol. Chem. 279 2004 37528 37534
14. A. Hoffmann G. Natoli G. Ghosh Transcriptional regulation via the NF-kappaB signaling module Oncogene 25 2006 6706 6716
15. C. Scheidereit IkappaB kinase complexes: gateways to NF-kappaB activation and transcription Oncogene 25 2006 6685 6705
16. K.A. Steinbrecher W. Wilson III P.C. Cogswell A.S. Baldwin Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription Mol. Cell. Biol. 25 2005 8444 8455
17. G. Sethi K.S. Ahn S.K. Sandur X. Lin M.M. Chaturvedi B.B. Aggarwal Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway J. Biol. Chem. 281 2006 23425 23435
18. P. Schotte G. van Loo I. Carpentier P. Vandenabeele R. Beyaert Lithium sensitizes tumor cells in an NF-kappa B-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF). Evidence for a role of the TNF receptor-associated death domain protein J. Biol. Chem. 276 2001 25939 25945
19. X. Li G.N. Bijur R.S. Jope Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection Bipolar. Disord. 4 2002 137 144
20. S. Sekine B.Y. Lan M. Bedolli S. Feng M. Hebrok Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice Hepatology 43 2006 817 825
21. X. Tan J. Behari B. Cieply G.K. Michalopoulos S.P. Monga Conditional deletion of beta-catenin reveals its role in liver growth and regeneration Gastroenterology 131 2006 1561 1572
22. R. Taub Liver regeneration: from myth to mechanism Nat. Rev., Mol. Cell Biol. 5 2004 836 847
23. U. Klingmuller A. Bauer S. Bohl P.J. Nickel K. Breitkopf S. Dooley S. Zellmer C. Kern I. Merfort T. Sparna J. Donauer G. Walz M. Geyer C. Kreutz M. Hermes F. Götschel A. Hecht D. Walter L. Egger K. Neubert C. Borner M. Brulport W. Schormann C. Sauer F. Baumann R. Preiss S. McNelly P. Godoy E. Wiercinska L. Ciuclan J. Edelmann K. Zeilinger M. Heinrich U.M. Zanger R. Gebhardt T. Maiwald R. Heinrich J. Timmer F. von Weizsäcker J.G. Hengstler Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways Syst. Biol. 153 2006 433 447
24. D. Porath C. Riegger J. Drewe J. Schwager Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines J. Pharmacol. Exp. Ther. 315 2005 1172 1180
25. N.A. Thornberry T.A. Rano E.P. Peterson D.M. Rasper T. Timkey M. Garcia-Calvo V.M. Houtzager P.A. Nordstrom S. Roy J.P. Vaillancourt K.T. Chapman D.W. Nicholson A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis J. Biol. Chem. 272 1997 17907 17911
26. A. Hecht C.M. Litterst O. Huber R. Kemler Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro J. Biol. Chem. 274 1999 18017 18025
27. H. Aberle A. Bauer J. Stappert A. Kispert R. Kemler Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J. 16 1997 3797 3804
28. M.P. Coghlan A.A. Culbert D.A. Cross S.L. Corcoran J.W. Yates N.J. Pearce O.L. Rausch G.J. Murphy P.S. Carter C.L. Roxbee D. Mills M.J. Brown D. Haigh R.W. Ward D.G. Smith K.J. Murray A.D. Reith J.C. Holder Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription Chem. Biol. 7 2000 793 803
29. H. Aberle H. Schwartz H. Hoschuetzky R. Kemler Single amino acid substitutions in proteins of the armadillo gene family abolish their binding to alpha-catenin The J. Biol. Chem. 271 1996 1520 1526
30. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
31. J. Deng W. Xia S.A. Miller Y. Wen H.Y. Wang M.C. Hung Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway Mol. Carcinog. 39 2004 139 146
32. W.J. Boyle T. Smeal L.H. Defize P. Angel J.R. Woodgett M. Karin T. Hunter Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity Cell 64 1991 573 584
33. S. Liu S. Yu Y. Hasegawa R. Lapushin H.J. Xu J.R. Woodgett G.B. Mills X. Fang Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase J. Biol. Chem. 279 2004 51075 51081
34. W. Wei J. Jin S. Schlisio J.W. Harper W.G. Kaelin The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase Cancer Cell 8 2005 25 33
35. P. Angel K. Hattori T. Smeal M. Karin The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 Cell 55 1988 875 885
36. A.S. Nateri B. Spencer-Dene A. Behrens Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development Nature 437 2005 281 285
37. M. Martin K. Rehani R.S. Jope S.M. Michalek Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nat. Immunol. 6 2005 777 784
38. C.A. Grimes R.S. Jope CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium J. Neurochem. 78 2001 1219 1232
39. J.M. Park F.R. Greten A. Wong R.J. Westrick J.S. Arthur K. Otsu A. Hoffmann M. Montminy M. Karin Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators Immunity 23 2005 319 329
40. H. Wajant K. Pfizenmaier P. Scheurich Tumor necrosis factor signaling Cell Death Different 10 2003 45 65
41. N. Mori D. Prager Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: identification and characterization of NF-kappa B binding sites in the regulatory region of the interleukin-10 gene Eur. J. Haematol. 59 1997 162 170
42. S. Cao X. Zhang J.P. Edwards D.M. Mosser NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages J. Biol. Chem. 281 2006 26041 26050
43. A.J. Garcia-Pineres V. Castro G. Mora T.J. Schmidt E. Strunck H.L. Pahl I. Merfort Cysteine 38 in p65/NF-kappa B plays a crucial role in DNA binding inhibition by sesquiterpene lactones J. Biol. Chem. 276 2001 39713 39720
44. M. Jove A. Planavila R.M. Sanchez M. Merlos J.C. Laguna M. Vazquez-Carrera Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation Endocrinology 147 2006 552 561
45. S.A. Laufer G.K. Wagner D.A. Kotschenreuther W. Albrecht Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes J. Med. Chem. 46 2003 3230 3244
46. R. Eferl M. Sibilia F. Hilberg A. Fuchsbichler I. Kufferath B. Guertl R. Zenz E.F. Wagner K. Zatloukal Functions of c-Jun in liver and heart development J. Cell Biol. 145 1999 1049 1061
47. R. Eferl R. Ricci L. Kenner R. Zenz J.P. David M. Rath E.F. Wagner Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53 Cell 112 2003 879 889
48. F. Hilberg A. Aguzzi N. Howells E.F. Wagner c-Jun is essential for normal mouse development and hepatogenesis Nature 365 1993 179 181
49. R.S. Johnson B. van Lingen V.E. Papaioannou B.M. Spiegelman A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture Genes & Dev. 7 1993 1309 1317
50. H. Xie Z. Huang M.S. Sadim Z. Sun Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL J. Immunol. 175 2005 7981 7988
51. M. Almeida L. Han T. Bellido S.C. Manolagas S. Kousteni Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT J. Biol. Chem. 280 2005 41342 41351
52. M. Mezhybovska K. Wikstrom J.F. Ohd A. Sjolander The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells J. Biol. Chem. 281 2006 6776 6784
53. E. Beurel R.S. Jope The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways Prog. Neurobiol. 79 2006 173 189
54. J. Deng S.A. Miller H.Y. Wang W. Xia Y. Wen B.P. Zhou Y. Li S.Y. Lin M.C. Hung Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer Cancer Cell 2 2002 323 334
55. X. Liao L. Zhang J.B. Thrasher J. Du B. Li Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer Mol. Cancer Ther. 2 2003 1215 1222
56. R. Margueron P. Trojer D. Reinberg The key to development: interpreting the histone code? Curr. Opin. Genet. Dev. 15 2005 163 176
57. X. Zeng K. Tamai B. Doble S. Li H. Huang R. Habas H. Okamura J. Woodgett X. He A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation Nature 438 2005 873 877
58. X.M. Yin Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways Cell Res. 10 2000 161 167
59. Y. Zhao W.X. Ding T. Qian S. Watkins J.J. Lemasters X.M. Yin Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement Gastroenterology 125 2003 854 867
60. C.J. Phiel P.S. Klein Molecular targets of lithium action Annu. Rev. Pharmacol. Toxicol. 41 2001 789 813
61. B.W. Doble S. Patel G.A. Wood L.K. Kockeritz J.R. Woodgett Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines Dev. Cell 12 2007 957 971
62. M.H. Liang D.M. Chuang Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation J. Biol. Chem. 281 2006 30479 30484
63. M.B. Bansal K. Kovalovich R. Gupta W. Li A. Agarwal B. Radbill C.E. Alvarez R. Safadi M.I. Fiel S.L. Friedman R.A. Taub Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression J. Hepatol. 42 2005 548 556
64. K. Kovalovich W. Li R. DeAngelis L.E. Greenbaum G. Ciliberto R. Taub Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL J. Biol. Chem. 276 2001 26605 26613
65. R. Taub Hepatoprotection via the IL-6/Stat3 pathway J. Clin. Invest. 112 2003 978 980
66. R. Safadi M. Ohta C.E. Alvarez M.I. Fiel M. Bansal W.Z. Mehal S.L. Friedman Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes Gastroenterology 127 2004 870 882
67. K. Thompson J. Maltby J. Fallowfield M. McAulay H. Millward-Sadler N. Sheron Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis Hepatology 28 1998 1597 1606
68. A. Wullaert K. Heyninck R. Beyaert Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes Biochem. Pharmacol. 72 2006 1090 1101
69. J.S. Gujral J. Liu A. Farhood J.A. Hinson H. Jaeschke Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice Am. J. Physiol. Gastrointest. Liver Physiol. 286 2004 G499 G507
70. K. Neubauer S.T. Eichhorst T. Wilfling M. Buchenau L. Xia G. Ramadori Sinusoidal intercellular adhesion molecule-1 up-regulation precedes the accumulation of leukocyte function antigen-1-positive cells and tissue necrosis in a model of carbontetrachloride-induced acute rat liver injury Lab. Invest. 78 1998 185 194
71. C.M. Hedgepeth L.J. Conrad J. Zhang H.C. Huang V.M. Lee P.S. Klein Activation of the Wnt signaling pathway: a molecular mechanism for lithium action Dev. Biol. 185 1997 82 91
72. C. Dunn C. Wiltshire A. MacLaren D.A. Gillespie Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor Cell. Signal. 14 2002 585 593
73. S. Morton R.J. Davis A. McLaren P. Cohen A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun EMBO J. 22 2003 3876 3886
74. Q. Wang Y. Zhou X. Wang B.M. Evers Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase Oncogene 25 2006 43 50
75. A. Vines S. Cahoon I. Goldberg U. Saxena S. Pillarisetti Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression J. Biol. Chem. 281 2006 16985 16990
76. S.P. Monga P. Pediaditakis K. Mule D.B. Stolz G.K. Michalopoulos Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration Hepatology 33 2001 1098 1109
77. S.P. Monga H.K. Monga X. Tan K. Mule P. Pediaditakis G.K. Michalopoulos Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification Gastroenterology 124 2003 202 216
78. P.G. Ekert A.M. Jabbour A. Manoharan J.E. Heraud J. Yu M. Pakusch E.M. Michalak P.N. Kelly B. Callus T. Kiefer A. Verhagen J. Silke A. Strasser C. Borner D.L. Vaux Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma Blood 108 2006 1461 1468